Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons

Nature Neuroscience

Volumn 16, Issue 10, 2013, Pages 1383-1391

  Wang, Wen Yuan ^a,b   Pan, Ling ^a,b   Su, Susan C ^a,b   Quinn, Emma J ^a,b   Sasaki, Megumi ^a,b   Jimenez, Jessica C ^a,b   MacKenzie, Ian R A ^c   Huang, Eric J ^d,e   Tsai, Li Huei ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUSED IN SARCOMA PROTEIN; HISTONE DEACETYLASE 1;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DNA STRAND BREAKAGE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NERVE CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLS, CULTURED; DNA DAMAGE; HEK293 CELLS; HISTONE DEACETYLASE 1; HUMANS; MICE; NEURONS; PROTEIN BINDING; RNA-BINDING PROTEIN FUS;

EID: 84884902129     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3514     Document Type: Article

References (51)

1. Rass, U., Ahel, I. &West, S.C. Defective DNA repair and neurodegenerative disease. Cell 130, 991-1004 (2007). (Pubitemid 47410275)
2. McKinnon, P.J. DNA repair deficiency and neurological disease. Nat. Rev. Neurosci. 10, 100-112 (2009).
3. Bender, A. et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38, 515-517 (2006).
4. Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891 (2004). (Pubitemid 38843301)
5. Anderson, A.J., Su, J.H. &Cotman, C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16, 1710-1719 (1996).
6. de Waard, M.C. et al. Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice. Acta Neuropathol. 120, 461-475 (2010).
7. Tan, A.Y. &Manley, J.L. The TET family of proteins: functions and roles in disease. J. Mol. Cell Biol. 1, 82-92 (2009).
8. Fujii, R. et al. The RNA-binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 15, 587-593 (2005). (Pubitemid 40413401)
9. Fujii, R. &Takumi, T. TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 118, 5755-5765 (2005). (Pubitemid 43079269)
10. Kuroda, M. et al. Male sterility and enhanced radiation sensitivity in TLS(/) mice. EMBO J. 19, 453-462 (2000). (Pubitemid 30072615)
11. Hicks, G.G. et al. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 24, 175-179 (2000). (Pubitemid 30094720)
12. Bertrand, P., Akhmedov, A.T., Delacote, F., Durrbach, A. &Lopez, B.S. Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. Oncogene 18, 4515-4521 (1999). (Pubitemid 29396659)
13. Baechtold, H. et al. Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J. Biol. Chem. 274, 34337-34342 (1999). (Pubitemid 129511776)
14. Gardiner, M.T.R., Vandermoere, F., Morrice, N.A. &Rouse, J. Identification and characterization of FUS/TLS as a new target of ATM. Biochem. J. 415, 297-307 (2008).
15. Wang, X. et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454, 126-130 (2008). (Pubitemid 351934270)
16. Vance, C. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211 (2009).
17. Kwiatkowski, T.J. Jr. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208 (2009).
18. Pierce, A.J., Johnson, R.D., Thompson, L.H. &Jasin, M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 13, 2633-2638 (1999). (Pubitemid 29508550)
19. Patel, K.J. et al. Involvement of Brca2 in DNA repair. Mol. Cell 1, 347-357 (1998). (Pubitemid 128378883)
20. Seluanov, A., Mittelman, D., Pereira-Smith, O.M., Wilson, J.H. &Gorbunova, V. DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc. Natl. Acad. Sci. USA 101, 7624-7629 (2004). (Pubitemid 38658079)
21. Ferguson, D.O. et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl. Acad. Sci. USA 97, 6630-6633 (2000). (Pubitemid 30412765)
22. Sharma, S. Age-related nonhomologous end joining activity in rat neurons. Brain Res. Bull. 73, 48-54 (2007). (Pubitemid 46710245)
23. Hande, K.R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 34, 1514-1521 (1998). (Pubitemid 28446331)
24. Fillingham, J., Keogh, M.C. &Krogan, N.J. GammaH2AX and its role in DNA double-strand break repair. Biochem. Cell Biol. 84, 568-577 (2006). (Pubitemid 44703660)
25. Anderson, L., Henderson, C. &Adachi, Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol. Cell Biol. 21, 1719-1729 (2001). (Pubitemid 32156392)
26. Keramaris, E., Hirao, A., Slack, R.S., Mak, T.W. &Park, D.S. Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage. J. Biol. Chem. 278, 37782-37789 (2003). (Pubitemid 37175305)
27. Kim, D. et al. Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60, 803-817 (2008).
28. Collins, A.R. The comet assay for DNA damage and repair: principles, applications and limitations. Mol. Biotechnol. 26, 249-261 (2004). (Pubitemid 41490465)
29. Pilch, D.R. et al. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem. Cell Biol. 81, 123-129 (2003). (Pubitemid 37076234)
30. Soutoglou, E. &Misteli, T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science 320, 1507-1510 (2008). (Pubitemid 351929432)
31. Weinstock, D.M., Nakanishi, K., Helgadottir, H.R. &Jasin, M. Assaying double-strand break repair pathway choice in mammalian cells using a targeted endonuclease or the RAG recombinase. Methods Enzymol. 409, 524-540 (2006).
32. Dobbin, M.M. et al. SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat. Neurosci. 16, 1008-1015 (2013).
33. Stark, J.M. et al. ATP hydrolysis by mammalian RAD51 has a key role during homology-directed DNA repair. J. Biol. Chem. 277, 20185-20194 (2002). (Pubitemid 34967310)
34. Huang, E.J. et al. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 20, 1069-1076 (2010).
35. Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411-2422 (1996). (Pubitemid 26341877)
36. Celeste, A. et al. Genomic instability in mice lacking histone H2AX. Science 296, 922-927 (2002). (Pubitemid 34464900)
37. Miller, K.M. et al. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat. Struct. Mol. Biol. 17, 1144-1151 (2010).
38. Pegoraro, G. et al. Ageing-related chromatin defects through loss of the NURD complex. Nat. Cell Biol. 11, 1261-1267 (2009).
39. Lukas, J., Lukas, C. &Bartek, J. More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance. Nat. Cell Biol. 13, 1161-1169 (2011).
40. Dinant, C., Houtsmuller, A.B. &Vermeulen, W. Chromatin structure and DNA damage repair. Epigenetics Chromatin. 1, 9 (2008).
41. Guan, J.S. et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55-60 (2009).
42. Gräff, J. et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 222-226 (2012).
43. Crozat, A., Aman, P., Mandahl, N. &Ron, D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644 (1993). (Pubitemid 23227627)
44. Ferrante, R.J. et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074 (1997). (Pubitemid 27452754)
45. Millecamps, S. et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet. 49, 258-263 (2012).
46. Huang, E.J. et al. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 20, 1069-1076 (2010).
47. Lois, C., Hong, E.J., Pease, S., Brown, E.J. &Baltimore, D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872 (2002). (Pubitemid 34118370)
48. Wang, W. et al. Genetically encoding unnatural amino acids for cellular and neuronal studies. Nat. Neurosci. 10, 1063-1072 (2007). (Pubitemid 47185200)
49. Gao, J. et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466, 1105-1109 (2010).
50. Kruhlak, M.J., Celeste, A. &Nussenzweig, A. Monitoring DNA breaks in optically highlighted chromatin in living cells by laser scanning confocal microscopy. Methods Mol. Biol. 523, 125-140 (2009).
51. Carpenter, A.E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7, R100 (2006).